ACCELERON PHARMA INC. Pre-Tax Income
ACCELERON PHARMA INC. reported Pre-Tax Income of -$70.45 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2021-11-04
- ACCELERON PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-09-30 was -$70.45M.
- ACCELERON PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-06-30 was -$63.51M.
- ACCELERON PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-03-31 was -$63.47M.
- ACCELERON PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-12-31 was -$57.41M.
- ACCELERON PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$166.01M.
- ACCELERON PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2019 was -$124.92M.
- ACCELERON PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2018 was -$118.90M.
- ACCELERON PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2017 was -$108.42M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$70.45M 10-Q · filed 2021-11-04 | -$133.96M derived: sum of 2 quarters · filed 2021-11-04 | -$197.43M 10-Q · filed 2021-11-04 | -$254.83M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | -$63.51M 10-Q · filed 2021-08-05 | -$126.98M 10-Q · filed 2021-08-05 | -$184.38M derived: sum of 3 quarters · filed 2021-08-05 | -$223.62M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-03-31 | -$63.47M 10-Q · filed 2021-05-06 | -$120.87M derived: sum of 2 quarters · filed 2021-05-06 | -$160.10M derived: sum of 3 quarters · filed 2021-11-04 | -$178.55M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-12-31 | -$57.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$96.64M derived: sum of 2 quarters · filed 2021-11-04 | -$115.09M derived: sum of 3 quarters · filed 2021-11-04 | -$166.01M 10-K · filed 2021-02-25 |
| 2020-09-30 | -$39.23M 10-Q · filed 2021-11-04 | -$57.68M derived: sum of 2 quarters · filed 2021-11-04 | -$108.60M 10-Q · filed 2021-11-04 | -$132.18M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$18.45M 10-Q · filed 2021-08-05 | -$69.37M 10-Q · filed 2021-08-05 | -$92.95M derived: sum of 3 quarters · filed 2021-08-05 | -$138.35M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$50.92M 10-Q · filed 2021-05-06 | -$74.50M derived: sum of 2 quarters · filed 2021-05-06 | -$119.91M derived: sum of 3 quarters · filed 2021-05-06 | -$137.81M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$23.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$68.98M derived: sum of 2 quarters · filed 2021-02-25 | -$86.89M derived: sum of 3 quarters · filed 2021-02-25 | -$124.92M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$45.40M 10-Q · filed 2020-11-05 | -$63.31M derived: sum of 2 quarters · filed 2020-11-05 | -$101.34M 10-Q · filed 2020-11-05 | -$136.11M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$17.91M 10-Q · filed 2020-08-06 | -$55.94M 10-Q · filed 2020-08-06 | -$90.71M derived: sum of 3 quarters · filed 2021-02-25 | -$119.70M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$38.03M 10-Q · filed 2020-05-11 | -$72.80M derived: sum of 2 quarters · filed 2021-02-25 | -$101.80M derived: sum of 3 quarters · filed 2021-02-25 | -$130.72M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$34.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$63.76M derived: sum of 2 quarters · filed 2021-02-25 | -$92.69M derived: sum of 3 quarters · filed 2021-02-25 | -$118.90M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$28.99M 10-Q · filed 2019-11-06 | -$57.92M derived: sum of 2 quarters · filed 2019-11-06 | -$84.13M 10-Q · filed 2019-11-06 | -$111.99M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$28.93M 10-Q · filed 2019-08-05 | -$55.13M 10-Q · filed 2019-08-05 | -$83.00M derived: sum of 3 quarters · filed 2020-02-27 | -$108.50M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$26.21M 10-Q · filed 2019-05-09 | -$54.08M derived: sum of 2 quarters · filed 2020-02-27 | -$79.57M derived: sum of 3 quarters · filed 2020-02-27 | -$109.23M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$27.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$53.36M derived: sum of 2 quarters · filed 2020-02-27 | -$83.02M derived: sum of 3 quarters · filed 2020-02-27 | -$108.42M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$25.49M 10-Q · filed 2018-10-30 | -$55.16M derived: sum of 2 quarters · filed 2018-10-30 | -$80.56M 10-Q · filed 2018-10-30 | -$99.80M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$29.66M 10-Q · filed 2018-08-02 | -$55.06M 10-Q · filed 2018-08-02 | -$74.31M derived: sum of 3 quarters · filed 2019-02-27 | -$95.10M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$25.40M 10-Q · filed 2018-05-08 | -$44.65M derived: sum of 2 quarters · filed 2019-02-27 | -$65.44M derived: sum of 3 quarters · filed 2019-02-27 | -$87.45M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$19.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$40.03M derived: sum of 2 quarters · filed 2019-02-27 | -$62.05M derived: sum of 3 quarters · filed 2019-02-27 | -$56.99M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$20.79M 10-Q · filed 2017-11-07 | -$42.81M derived: sum of 2 quarters · filed 2017-11-07 | -$37.74M 10-Q · filed 2017-11-07 | -$64.83M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$22.02M 10-Q · filed 2017-08-03 | -$16.96M 10-Q · filed 2017-08-03 | -$44.04M derived: sum of 3 quarters · filed 2018-02-27 | -$55.90M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $5.06M 10-Q · filed 2017-05-08 | -$22.02M derived: sum of 2 quarters · filed 2018-02-27 | -$33.88M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | -$27.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$38.94M derived: sum of 2 quarters · filed 2018-02-27 | -$63.89M 10-K · filed 2018-02-27 | |
| 2015-09-30 | -$11.86M 10-Q · filed 2016-11-03 | -$36.81M 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | -$51.26M 10-K · filed 2017-03-01 |